The Role of Platelet Cell Surface P-Selectin for the Direct Platelet-Tumor Cell Contact During Metastasis Formation in Human Tumors
暂无分享,去创建一个
[1] D. Ichikawa,et al. Platelets enhance malignant behaviours of gastric cancer cells via direct contacts , 2020, British Journal of Cancer.
[2] R. Muschel,et al. Platelets and Metastasis: New Implications of an Old Interplay , 2020, Frontiers in Oncology.
[3] C. Heldin,et al. Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis , 2020, Cancer Research.
[4] J. Kinoshita,et al. Extravasated platelet aggregation contributes to tumor progression via the accumulation of myeloid-derived suppressor cells in gastric cancer with peritoneal metastasis , 2020, Oncology letters.
[5] L. Borsig,et al. Non-Anticoagulant Heparan Sulfate from the Ascidian Phallusia nigra Prevents Colon Carcinoma Metastasis in Mice by Disrupting Platelet-Tumor Cell Interaction , 2020, Cancers.
[6] T. Lange,et al. Systematic analysis of the human tumor cell binding to human vs. murine E- and P-selectin under static vs. dynamic conditions , 2020, Glycobiology.
[7] P. Jayaraman,et al. Blood platelets stimulate cancer extravasation through TGFβ-mediated downregulation of PRH/HHEX , 2020, Oncogenesis.
[8] Wu-Hu Zhang,et al. Tumor-infiltrating platelets predict postoperative recurrence and survival in resectable pancreatic neuroendocrine tumor , 2019, World journal of gastroenterology.
[9] Cynthia A. Reinhart-King,et al. Engineered models to parse apart the metastatic cascade , 2019, npj Precision Oncology.
[10] K. Bieback,et al. Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: A joint publication from the AABB and the International Society of Cell Therapy. , 2019, Cytotherapy.
[11] J. Mitchell,et al. Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2 , 2019, The Journal of clinical investigation.
[12] M. Falasca,et al. The History of Armand Trousseau and Cancer-Associated Thrombosis , 2019, Cancers.
[13] U. Schumacher,et al. The functional role of integrins during intra- and extravasation within the metastatic cascade , 2019, Molecular Cancer.
[14] K. Pantel,et al. Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes , 2018, Scientific Reports.
[15] M. Schlesinger. Role of platelets and platelet receptors in cancer metastasis , 2018, Journal of Hematology & Oncology.
[16] W. Jin,et al. Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma , 2018, Annals of Surgical Oncology.
[17] M. Holinstat,et al. Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases , 2018, Pharmacological Reviews.
[18] M. Mastrogiacomo,et al. Culture Medium Supplements Derived from Human Platelet and Plasma: Cell Commitment and Proliferation Support , 2017, Front. Bioeng. Biotechnol..
[19] Lu Jiang,et al. Platelet microparticle-mediated transfer of miR-939 to epithelial ovarian cancer cells promotes epithelial to mesenchymal transition , 2017, Oncotarget.
[20] Stefan Offermanns,et al. Intravascular Survival and Extravasation of Tumor Cells. , 2017, Cancer cell.
[21] J. Wrana. Faculty of 1000 evaluation for Metastasis: new functional implications of platelets and megakaryocytes. , 2017 .
[22] M. Hennig,et al. Platelets subvert T cell immunity against cancer via GARP-TGFβ axis , 2017, Science Immunology.
[23] H. Levine,et al. EMT and MET: necessary or permissive for metastasis? , 2017, bioRxiv.
[24] Thomas R. Cox,et al. Pre-metastatic niches: organ-specific homes for metastases , 2017, Nature Reviews Cancer.
[25] R. Weinberg,et al. Emerging Biological Principles of Metastasis , 2017, Cell.
[26] Xuetao Cao,et al. Characteristics and Significance of the Pre-metastatic Niche. , 2016, Cancer cell.
[27] E. Gulbins,et al. Melanoma cell metastasis via P-selectin-mediated activation of acid sphingomyelinase in platelets , 2016, Clinical & Experimental Metastasis.
[28] S. Ishikawa,et al. Platelets surrounding primary tumor cells are related to chemoresistance. , 2016, Oncology reports.
[29] G. Scambia,et al. Culture of human cell lines by a pathogen-inactivated human platelet lysate , 2016, Cytotechnology.
[30] O. Peyruchaud,et al. Metastasis: new functional implications of platelets and megakaryocytes. , 2016, Blood.
[31] J. Segall,et al. Tumor cell intravasation. , 2016, American journal of physiology. Cell physiology.
[32] Andrew R. Chin,et al. Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications , 2016, Clinical Cancer Research.
[33] Nailin Li. Platelets in cancer metastasis: To help the “villain” to do evil , 2016, International journal of cancer.
[34] K. Lauber,et al. Platelets Guide Leukocytes to Their Sites of Extravasation , 2016, PLoS biology.
[35] Mengjie Yan,et al. The role of platelets in the tumor microenvironment: From solid tumors to leukemia. , 2016, Biochimica et biophysica acta.
[36] N. Zhang,et al. Replacing the Promoter of the Murine Gene Encoding P-selectin with the Human Promoter Confers Human-like Basal and Inducible Expression in Mice* , 2015, The Journal of Biological Chemistry.
[37] J. Banyard,et al. The role of EMT and MET in cancer dissemination , 2015, Connective tissue research.
[38] A. Weyrich,et al. Regulation of the genetic code in megakaryocytes and platelets , 2015, Journal of thrombosis and haemostasis : JTH.
[39] K. Barbee,et al. An in vitro model of the tumor-lymphatic microenvironment with simultaneous transendothelial and luminal flows reveals mechanisms of flow enhanced invasion. , 2015, Integrative biology : quantitative biosciences from nano to macro.
[40] Hongwei Liang,et al. MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3 , 2015, Molecular Cancer.
[41] Liu Cao,et al. P-selectin-mediated platelet adhesion promotes tumor growth , 2015, Oncotarget.
[42] Sridhar Ramaswamy,et al. Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.
[43] R. Weinberg,et al. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis , 2014, Nature Cell Biology.
[44] R. Hynes,et al. Platelets guide the formation of early metastatic niches , 2014, Proceedings of the National Academy of Sciences.
[45] Li-jing Wang,et al. P-Selectin-Mediated Platelet Adhesion Promotes the Metastasis of Murine Melanoma Cells , 2014, PloS one.
[46] A. Sood,et al. Platelets and cancer: a casual or causal relationship: revisited , 2014, Cancer and Metastasis Reviews.
[47] B. Carr,et al. Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro , 2014, BMC Cancer.
[48] S. Offermanns,et al. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. , 2013, Cancer cell.
[49] R. Escorpizo,et al. Challenges and Opportunities , 1999, Deep Eutectic Solvents for Pretreatment of Lignocellulosic Biomass.
[50] T. Brabletz. EMT and MET in metastasis: where are the cancer stem cells? , 2012, Cancer cell.
[51] A. Sood,et al. Platelets increase the proliferation of ovarian cancer cells. , 2012, Blood.
[52] Richard O Hynes,et al. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. , 2012, Cancer discovery.
[53] B. Chong,et al. Platelets and P-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells. , 2012, Cancer research.
[54] U. Schumacher,et al. Selectin-deficiency reduces the number of spontaneous metastases in a xenograft model of human breast cancer. , 2012, Cancer letters.
[55] J. Freedman,et al. Platelets and platelet-like particles mediate intercellular RNA transfer. , 2012, Blood.
[56] G. Adam,et al. Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp−−/rag2−− mice , 2012, Gut.
[57] H. Rammensee,et al. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. , 2012, Cancer research.
[58] R. Black,et al. Modelling the lymphatic system: challenges and opportunities , 2012, Journal of The Royal Society Interface.
[59] Richard O Hynes,et al. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. , 2011, Cancer cell.
[60] T. Wurdinger,et al. Blood platelets contain tumor-derived RNA biomarkers. , 2011, Blood.
[61] M. Chatterjee,et al. Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli. , 2011, Blood.
[62] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[63] Laurie J. Gay,et al. Contribution of platelets to tumour metastasis , 2011, Nature Reviews Cancer.
[64] F. Lupu,et al. Differential regulation of human and murine P-selectin expression and function in vivo , 2010, The Journal of experimental medicine.
[65] P. Sonneveld,et al. Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma , 2010, Thrombosis and Haemostasis.
[66] M. Schön,et al. Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. , 2010, Blood.
[67] A. Kakkar,et al. Antithrombotic therapy and survival in patients with malignant disease , 2010, British Journal of Cancer.
[68] L. Borsig. Antimetastatic activities of heparins and modified heparins. Experimental evidence. , 2010, Thrombosis research.
[69] Yan-guang Gao,et al. Modified heparins inhibit integrin αIIbβ3 mediated adhesion of melanoma cells to platelets in vitro and in vivo , 2009, International journal of cancer.
[70] Erik Sahai,et al. Localised and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility , 2009, Nature Cell Biology.
[71] J. Colon,et al. Tissue factor‐bearing microparticles derived from tumor cells: impact on coagulation activation , 2008, Journal of thrombosis and haemostasis : JTH.
[72] George Poste,et al. The "seed and soil" hypothesis revisited. , 2008, The Lancet. Oncology.
[73] G. Mundy. The premetastatic niche , 2008 .
[74] J. Folkman,et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. , 2008, Blood.
[75] A. Varki. Trousseau's syndrome: multiple definitions and multiple mechanisms. , 2007, Blood.
[76] E. Akl,et al. Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation. , 2007, The Cochrane database of systematic reviews.
[77] R. Sanderson,et al. Non-Anticoagulant Heparins and Inhibition of Cancer , 2007, Pathophysiology of Haemostasis and Thrombosis.
[78] S. Rafii,et al. Preparing the "soil": the premetastatic niche. , 2006, Cancer research.
[79] J. Massagué,et al. Cancer Metastasis: Building a Framework , 2006, Cell.
[80] J. Quigley,et al. Matrix metalloproteinases and tumor metastasis , 2006, Cancer and Metastasis Reviews.
[81] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[82] Birgit Kasch,et al. Next Generation , 2005, Im OP.
[83] K. Swoboda,et al. Escaping the Nuclear Confines: Signal-Dependent Pre-mRNA Splicing in Anucleate Platelets , 2005, Cell.
[84] I. Fidler,et al. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.
[85] Ajit Varki,et al. Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[86] Alan Wells,et al. Growth Factor-Induced Cell Motility in Tumor Invasion , 2002, Acta oncologica.
[87] D. Fishman,et al. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. , 2001, Cancer research.
[88] David R. Nadeau,et al. Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[89] G. Lip,et al. Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[90] R K Jain,et al. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[91] O. McCarty,et al. Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions. , 2000, Blood.
[92] F. Taylor,et al. Divergent inducible expression of P-selectin and E-selectin in mice and primates. , 1999, Blood.
[93] N. Ferrara. Role of vascular endothelial growth factor in the regulation of angiogenesis. , 1999, Kidney international.
[94] B. Echtenacher,et al. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. , 1999, Cancer research.
[95] P. Vermeulen,et al. Blood platelets and serum VEGF in cancer patients , 1999, British Journal of Cancer.
[96] A. Varki,et al. P-selectin deficiency attenuates tumor growth and metastasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[97] Junliang Pan,et al. Comparison of Promoters for the Murine and Human P-selectin Genes Suggests Species-specific and Conserved Mechanisms for Transcriptional Regulation in Endothelial Cells* , 1998, The Journal of Biological Chemistry.
[98] Junliang Pan,et al. Tumor Necrosis Factor-α- or Lipopolysaccharide-induced Expression of the Murine P-selectin Gene in Endothelial Cells Involves Novel κB Sites and a Variant Activating Transcription Factor/cAMP Response Element* , 1998, The Journal of Biological Chemistry.
[99] S. Rafii,et al. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[100] A. Varki,et al. Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins. , 1995, Cancer research.
[101] Junliang Pan,et al. Regulation of the Human P-selectin Promoter by Bcl-3 and Specific Homodimeric Members of the NF-κB/Rel Family (*) , 1995, The Journal of Biological Chemistry.
[102] J. Pan,et al. Characterization of the promoter for the human P-selectin gene. , 1993, The Journal of biological chemistry.
[103] I. Fahrenfort,et al. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. , 1993, The Biochemical journal.
[104] D. Vestweber,et al. Cloning of the mouse endothelial selectins. Expression of both E- and P-selectin is inducible by tumor necrosis factor alpha. , 1992, The Journal of biological chemistry.
[105] Y. Katagiri,et al. Characterization of platelet aggregation induced by the human melanoma cell line HMV-I: roles of heparin, plasma adhesive proteins, and tumor cell membrane proteins. , 1991, Cancer research.
[106] O. Berthier‐Vergnes,et al. Platelet-melanoma cell interaction is mediated by the glycoprotein IIb-IIIa complex. , 1989, Blood.
[107] S. Karpatkin,et al. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. , 1988, The Journal of clinical investigation.
[108] M. Sporn,et al. Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells , 1986, The Journal of cell biology.
[109] H. Al-Mondhiry. Beta‐thromboglobulin and platelet‐factor 4 in patients with cancer: Correlation with the stage of disease and the effect of chemotherapy , 1983, American journal of hematology.
[110] C. Stewart,et al. Antimetastatic effects associated with platelet reduction. , 1968, Proceedings of the National Academy of Sciences of the United States of America.
[111] J. Harmon,et al. Metastasis-promoting role of extravasated platelet activation in tumor. , 2015, The Journal of surgical research.
[112] R. Matkowski,et al. Circulating Tumor , 2014 .
[113] J. Freedman,et al. New paradigms in thrombosis: novel mediators and biomarkers platelet RNA transfer , 2013, Journal of Thrombosis and Thrombolysis.
[114] E. van Marck,et al. Platelets and vascular endothelial growth factor (VEGF): A morphological and functional study , 2004, Angiogenesis.
[115] Bonnie F. Sloane,et al. Tumor cell-platelet interactions in vitro and their relationship to in vivo arrest of hematogenously circulating tumor cells , 2004, Clinical & Experimental Metastasis.
[116] H. Beug,et al. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. , 1998, Current biology : CB.
[117] S. Pulman. Building the Framework , 1996 .
[118] F. Marcucci,et al. Treatment with modified heparins inhibits experimental metastasis formation and leads, in some animals, to long-term survival. , 1996, Invasion & metastasis.
[119] A. Varki,et al. Perspectives Series: Cell Adhesion in Vascular Biology Selectin Ligands: Will the Real Ones Please Stand Up? , 2022 .